Interestingly, ANP, a marker often used for ventricular hypertrophy was not significantly increased in the atria, most likely due to the already high baseline expression levels of ANP in the atria (75-fold higher in the atria compared to the ventricles). Here, NPPA is linked to cardiac hypertrophy.